Genetic Prodrug Activation in erbB-2 Overexpressing Breast Cancer

Breast Cancer Research - United Kingdom
doi 10.1186/bcr-1999-66591
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Role of Adenoviral Vectors in Genetic Prodrug Activation Therapy in Prostate Cancer

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2000English

ErbB-2 Nuclear Function in Breast Cancer Growth, Metastasis and Resistance to Therapy

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2016English

ERBB-Receptors and Drug Response in Breast Cancer

1997English

Activation of Stat3 by Heregulin/ErbB-2 Through the Co-Option of Progesterone Receptor Signaling Drives Breast Cancer Growth

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2008English

The Angiogenic Secretome in VEGF Overexpressing Breast Cancer Xenografts

Scientific Reports
Multidisciplinary
2016English

Progesterone Receptor Induces ErbB-2 Nuclear Translocation to Promote Breast Cancer Growth via a Novel Transcriptional Effect: ErbB-2 Function as a Coactivator of Stat3

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2010English

MNK1 and MNK2 Regulation in HER2-overexpressing Breast Cancer Lines

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Therapy of Advanced Established Murine Breast Cancer With a Recombinant Adenoviral ErbB-2/neu Vaccine

Cancer Research
Cancer ResearchOncology
2008English

ErbB-2/Her2/neu Overexpression and Estrogen-Dependency in Breast Carcinogenesis

2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy